Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Qu Xiaoxuan (Last) (First) (Middle) 17571 VON KARMAN AVE (Street) IRVINE CA 92614 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 08/27/2026	3. Issuer Name and Ticker or Trading Symbol BIOMERICA INC [ BMRA ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) See Remarks	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	04/10/2036	Common Stock	4,300	$2.13	D
Stock Option (Right to Buy)	(2)	01/09/2035	Common Stock	4,188	$2.64	D
Stock Option (Right to Buy)	(3)	01/18/2034	Common Stock	1,875	$7.28	D
Stock Option (Right to Buy)	(4)	08/21/2033	Common Stock	1,000	$9.44	D

Explanation of Responses:

1. The option vests in four equal annual installments beginning on April 10, 2027, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.

2. The option vests in four equal annual installments beginning on January 9, 2026, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.

3. The option vests in four equal annual installments beginning on January 18, 2025, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.

4. The option vests in four equal annual installments beginning on August 21, 2024, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.

Remarks:

Principal Financial Officer and Principal Accounting Officer

	/s/ Xiaoxuan Qu	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.